Adverse effect of anticholinesterase agents, sequela

This code signifies a patient experiencing a harmful or unintended reaction to medications that inhibit acetylcholinesterase, such as those used to treat myasthenia gravis or Alzheimer's disease. The "sequela" designation indicates that this adverse effect is a late effect or complication of the initial reaction, rather than an acute event.

Apply this code when documentation clearly states a patient is suffering from a long-term consequence or residual effect directly attributable to a past adverse reaction to an anticholinesterase agent. This might include persistent neurological symptoms, gastrointestinal issues, or other chronic conditions that developed as a result of the initial adverse drug event.

• Ensure the documentation explicitly links the current condition to a past adverse effect of an anticholinesterase agent.
• Do not use for acute adverse reactions; those would typically fall under the initial encounter codes.
• Always code the specific manifestation of the sequela first, followed by this code to indicate the cause.